Latest News about EXAS
Recent news which mentions EXAS
2 Top Biotech Stocks to Buy for the Long Haul
April 07, 2022
From Motley Fool
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood's Top 10 Bets Are Faring In 2022 So Far
March 14, 2022
From Benzinga
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility
February 28, 2022
From MarketWatch
Invest in Next-Gen Technologies With These 2 ETFs
February 24, 2022
From Motley Fool
Exact Sciences Clocks 16% Jump In Q4 Non-COVID-19 Revenues
February 23, 2022
Tickers
EXAS
From Benzinga
4 Big Ark Innovation Components Report Earnings This Week: Could It Spell More Danger For Cathie Wood?
February 23, 2022
From Benzinga
Exact Sciences (EXAS) Q4 2021 Earnings Call Transcript
February 23, 2022
Tickers
EXAS
From Motley Fool
Earnings Scheduled For February 22, 2022
February 22, 2022
From Benzinga
3 Stocks to Avoid This Week
February 21, 2022
From Motley Fool
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 18, 2022
From Benzinga
From Benzinga
2 Beaten-Down Cathie Wood Growth Stocks to Buy and Hold For 10 Years
January 25, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 20, 2022
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
From Benzinga
2 Reasons to Buy Exact Sciences Stock, and 1 Reason to Sell
December 07, 2021
Tickers
EXAS
From Motley Fool
Exact Sciences Breaks Up With Pfizer -- Time to Buy?
December 01, 2021
From Motley Fool
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
From Benzinga
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
November 29, 2021
From Motley Fool
These 2 Cathie Wood Stocks Are Screaming Buys
November 24, 2021
From Motley Fool
3 Beaten-Down Genomics Stocks: Can They Recover?
November 16, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.